Lenalidomide based triplets in relapsed/refractory multiple myeloma: analysis of the Czech Myeloma Group

Lenalidomide based triplets in relapsed/refractory multiple myeloma: analysis of the Czech Myeloma Group

Abstract Despite significant advancements in therapy of multiple myeloma (MM) over the past 20 years, most patients experience relapse, necessitating new treatment approaches. This study aims to compare the real-world effectiveness of lenalidomide (LEN)-based triplet therapies, specifically daratumu...

Full description

Saved in:
Bibliographic Details
Main Authors: Jiri Minarik, Ludek Pour, Vojtech Latal, Tomas Jelinek, Jan Straub, Alexandra Jungova, Jakub Radocha, Petr Pavlicek, Martin Stork, Tomas Pika, Petra Krhovska, Tereza Popkova, Frantisek Sedlak, Ivan Spicka, Pavel Jindra, Vladimira Capounova, Vladimir Maisnar, Roman Hajek
Format: Article
Language:English
Published: BMC 2025-04-01
Series:BMC Cancer
Subjects:
Multiple myeloma
Relapsed/refractory
Lenalidomide triplets
Risk groups
Online Access:https://doi.org/10.1186/s12885-025-14087-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12885-025-14087-y

Similar Items